BIOVENTUS_LOGO.png
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
December 06, 2023 08:00 ET | Bioventus, Inc.
DURHAM, N.C., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract...
BIOVENTUS_LOGO.png
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
November 07, 2023 07:00 ET | Bioventus, Inc.
DURHAM, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
BIOVENTUS_LOGO.png
Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023
October 31, 2023 07:00 ET | Bioventus, Inc.
DURHAM, N.C., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
BIOVENTUS_LOGO.png
Bioventus to Present at the Cantor Global Healthcare Conference
September 19, 2023 21:52 ET | Bioventus, Inc.
DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief...
BIOVENTUS_LOGO.png
Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023 16:30 ET | Bioventus, Inc.
DURHAM, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Tony Bihl, interim chief executive officer,...
BIOVENTUS_LOGO.png
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
August 08, 2023 07:30 ET | Bioventus, Inc.
DURHAM, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
BIOVENTUS_LOGO.png
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
August 04, 2023 08:30 ET | Bioventus, Inc.
DURHAM, N.C., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief...
BIOVENTUS_LOGO.png
Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023
August 01, 2023 17:35 ET | Bioventus, Inc.
DURHAM, N.C., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
BIOVENTUS_LOGO.png
Bioventus Completes Divestiture of its Wound Business
May 23, 2023 07:30 ET | Bioventus, Inc.
DURHAM, N.C., May 23, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has...
BIOVENTUS_LOGO.png
Bioventus Reports First Quarter Financial Results
May 16, 2023 16:15 ET | Bioventus, Inc.
DURHAM, N.C., May 16, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...